M/s. Planet Pharmaceutical Limited Pharmaceutical Import Profile — Tanzania (DGFT 2022–2026)

Name: M/s. Planet Pharmaceutical Limited Pharmaceutical Import Records from India — 3 Products, $540.7K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

M/s. Planet Pharmaceutical Limited — Pharmaceutical Importer Profile (2026) | 3 Products, $540.7K Trade | TransData Nexus

M/s. Planet Pharmaceutical Limited

Pharmaceutical Importer · Tanzania · Advanced Antibiotics Focus · $540.7K Total Trade · DGFT Verified

M/s. Planet Pharmaceutical Limited is a pharmaceutical importer based in Tanzania with a total trade value of $540.7K across 3 products in 3 therapeutic categories. Based on 14 verified import shipments from Indian Customs (DGFT) records, M/s. Planet Pharmaceutical Limited is the #1 buyer in 1 product including Metronidazole. M/s. Planet Pharmaceutical Limited sources from 1 verified Indian supplier, with Medopharm accounting for 100.0% of imports.

M/s. Planet Pharmaceutical Limited — Import Portfolio & Supplier Network

M/s. Planet Pharmaceutical Limited import network — 3 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to M/s. Planet Pharmaceutical Limited?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Medopharm	$400.8K	16	100.0%

M/s. Planet Pharmaceutical Limited sources from 1 verified Indian supplier across 16 distinct formulations. The sourcing is highly concentrated — Medopharm accounts for 100.0% of total imports, indicating a strategic single-source relationship.

What Formulations Does M/s. Planet Pharmaceutical Limited Import?

Formulation	Value	Ships
Griseofulvin tablets BP 500MG (25000 x	$50.0K	1
Metronidazole tablets BP 200MG (230000	$50.0K	1
Griseofulvin tablets BP 500MG (12000 x	$50.0K	1
Griseofulvin tablets BP 500MG (13000 x	$50.0K	1
Cledomox 625 (co amoxiclav tablets BP	$42.7K	1
Hyoscine butyl bromide tablets 10MG	$35.5K	1
Methyldopa tablets BP 250MG (10000 x	$30.5K	1
Furosemide tablets BP 40MG (30000 x 10	$18.0K	1
Promethazine hydrochloride tablets BP	$17.7K	1
Ibuprofen tabs BP 200MG (20000 x 10 x	$14.8K	1
Furosemide tablets BP 40MG (20000 x	$12.0K	1
Gastro resistant omeprazole capsules	$11.5K	1
Ibuprofen tabs BP 200MG (10000 x 10 x	$7.4K	1
Phenytoin tablets BP 100MG (5000 x 10	$4.3K	1
Haloperidol tablets BP 1.5MG (4975 x	$3.2K	1

Import Portfolio — Top 3 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Metronidazole	Advanced Antibiotics	$350.0K	7	0.2%	1
2	Griseofulvin	Advanced Antifungals	$150.0K	3	0.4%	9
3	Volini	Brand Names & OTC Products	$40.7K	4	1.4%	11

M/s. Planet Pharmaceutical Limited imports 3 pharmaceutical products across 3 categories into Tanzania totaling $540.7K. The company is the #1 buyer for 1 product: Metronidazole.

M/s. Planet Pharmaceutical Limited — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

M/s. Planet Pharmaceutical Limited is a prominent pharmaceutical importer and distributor based in Dar es Salaam, Tanzania. Established in 2009, the company commenced operations in 2010, focusing on the wholesale distribution of pharmaceutical products. Over the years, Planet Pharmaceutical Limited has expanded its footprint within Tanzania, establishing branches in Mwanza (2013), Arusha (2015), and Shinyanga (2018), thereby enhancing its distribution capabilities across the country. (planetpharmatz.co.tz)

The company's mission is to improve the health and wellness of the Tanzanian population by expanding access to high-quality pharmaceutical products. This commitment is reflected in their extensive portfolio, which includes a range of generic pharmaceuticals and branded over-the-counter consumer products. Planet Pharmaceutical Limited serves a diverse clientele, including private and public hospitals, government institutions, non-governmental organizations, and both retail and wholesale pharmacies.

2Distribution Network

Planet Pharmaceutical Limited operates a robust distribution network with strategically located warehouses in Dar es Salaam, Mwanza, Arusha, and Shinyanga. This geographic spread ensures efficient coverage of Tanzania's key regions, facilitating timely delivery of pharmaceutical products to various stakeholders. The company's logistics capabilities are designed to handle a diverse product range, including finished pharmaceutical formulations such as tablets, capsules, syrups, and injections. While specific details about their shipping routes and international logistics partners are not publicly disclosed, the company's established presence in multiple Tanzanian regions indicates a well-organized and resilient distribution system.

3Industry Role

In Tanzania's pharmaceutical supply chain, Planet Pharmaceutical Limited functions primarily as a wholesaler and distributor. By importing and distributing a wide array of pharmaceutical products, the company plays a crucial role in ensuring the availability of essential medicines across the country. Their operations encompass sourcing products from international markets, including India, China, and Pakistan, and supplying them to various healthcare providers, including hospitals, pharmacies, and government institutions. This intermediary role positions Planet Pharmaceutical Limited as a key player in the Tanzanian pharmaceutical sector, bridging the gap between international manufacturers and local healthcare providers. (planetpharmatz.co.tz)

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — M/s. Planet Pharmaceutical Limited

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Planet Pharmaceutical Limited's sourcing strategy exhibits a high degree of concentration, with a significant reliance on a single supplier, MEDOPHARM, accounting for 100% of their imports from India. This exclusive partnership underscores a strategic choice to maintain a consistent supply of pharmaceutical products, potentially benefiting from favorable terms and streamlined logistics. However, such dependency also introduces risks, particularly if MEDOPHARM faces operational challenges or supply chain disruptions. The absence of alternative suppliers could lead to vulnerabilities in product availability and pricing. The company's shipment data, comprising 16 shipments from MEDOPHARM, suggests a stable and ongoing relationship, yet the lack of diversification in sourcing could be a concern for long-term supply chain resilience.

2Supply Chain Resilience

The resilience of Planet Pharmaceutical Limited's supply chain is closely tied to its exclusive relationship with MEDOPHARM. While this partnership may offer benefits such as consistent product quality and favorable terms, it also poses risks associated with single-source dependency. The company's reliance on a single supplier for all imports from India means that any disruptions at MEDOPHARM—be it due to production issues, regulatory challenges, or logistical problems—could significantly impact Planet Pharmaceutical Limited's ability to meet market demand. The absence of backup suppliers and limited diversification in product formulations further exacerbate this vulnerability. To enhance supply chain resilience, it would be prudent for Planet Pharmaceutical Limited to consider diversifying its supplier base and incorporating a broader range of formulations into its portfolio.

Importing Pharmaceuticals into Tanzania — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Tanzania

1Regulatory Authority & Framework

The Tanzania Medicines and Medical Devices Authority (TMDA) is the primary regulatory body overseeing the importation and exportation of pharmaceutical products in Tanzania. Established under the Tanzania Medicines and Medical Devices Act, Cap. 219, TMDA is responsible for ensuring the safety, efficacy, and quality of medicines and medical devices within the country. Key legislation governing pharmaceutical imports includes the Pharmaceutical and Poisons Act, which outlines the control of manufacture, sale, import, and export of pharmaceutical products. The registration of pharmaceutical products is mandated under these regulations, requiring that all imported medicines be registered with TMDA prior to entry into the Tanzanian market.

2Import Licensing & GMP

Importers of pharmaceutical products in Tanzania must obtain a valid import license from TMDA, which is issued upon application and payment of the prescribed fee. The application process involves providing necessary documentation and information as required by the Authority. Importers are also required to register their premises with TMDA before applying for permits. Regarding Good Manufacturing Practice (GMP), TMDA recognizes certifications from reputable authorities, including the European Union (EU) GMP, World Health Organization (WHO) GMP, and the Pharmaceutical Inspection Co-operation Scheme (PIC/S). Imported pharmaceutical products must be sourced from manufacturers holding such recognized GMP certifications to ensure compliance with Tanzanian regulatory standards. (tmda.go.tz)

M/s. Planet Pharmaceutical Limited — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Planet Pharmaceutical Limited's product strategy focuses on importing and distributing a range of pharmaceutical products, including advanced antibiotics, advanced antifungals, and brand-name over-the-counter (OTC) products. The company's portfolio is heavily weighted towards advanced antibiotics, which constitute 64.7% of their imports, followed by advanced antifungals at 27.7%, and brand-name OTC products at 7.5%. This strategic focus aligns with the significant demand for these therapeutic categories in Tanzania, addressing prevalent health concerns such as infections and fungal diseases. The company's position as the number one buyer of metronidazole, a key antibiotic, underscores its commitment to meeting the country's healthcare needs in these areas.

2Sourcing Profile

Planet Pharmaceutical Limited's sourcing strategy is centered on importing finished pharmaceutical formulations from India, with a particular emphasis on products manufactured by MEDOPHARM. This approach reflects a preference for sourcing from suppliers with recognized GMP certifications, ensuring compliance with Tanzanian regulatory standards. The company's exclusive relationship with MEDOPHARM indicates a strategic choice to maintain a consistent supply of high-quality products, potentially benefiting from favorable terms and streamlined logistics. However, this single-source dependency also introduces risks related to supply chain disruptions and pricing fluctuations.

Seller's Guide — How to Become a Supplier to M/s. Planet Pharmaceutical Limited

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to enter the Tanzanian market through partnerships with Planet Pharmaceutical Limited. The company's exclusive sourcing relationship with MEDOPHARM suggests that alternative suppliers could offer differentiated products or competitive pricing to appeal to Planet Pharmaceutical Limited's strategic objectives. To identify gaps in the company's current

TransData Nexus Research · Industry procurement practicesMar 2026

Frequently Asked Questions — M/s. Planet Pharmaceutical Limited

What products does M/s. Planet Pharmaceutical Limited import from India?

M/s. Planet Pharmaceutical Limited imports 3 pharmaceutical products across 3 categories. Top imports: Metronidazole ($350.0K), Griseofulvin ($150.0K), Volini ($40.7K).

Who supplies pharmaceuticals to M/s. Planet Pharmaceutical Limited from India?

M/s. Planet Pharmaceutical Limited sources from 1 verified Indian suppliers. The primary supplier is Medopharm (100.0% of imports, $400.8K).

What is M/s. Planet Pharmaceutical Limited's total pharmaceutical import value?

M/s. Planet Pharmaceutical Limited's total pharmaceutical import value from India is $540.7K, based on 14 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does M/s. Planet Pharmaceutical Limited focus on?

M/s. Planet Pharmaceutical Limited imports across 3 categories. The largest: Advanced Antibiotics (64.7%), Advanced Antifungals (27.7%), Brand Names & OTC Products (7.5%).

Get Full M/s. Planet Pharmaceutical Limited Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 3 company name variants from customs records. For current shipment-level data, contact TransData Nexus.